About us

Ophidion, Inc. is an early-stage central nervous system (CNS) biopharmaceutical company leveraging its unique proprietary carrier technology to non-invasively deliver gene-silencing reagents and other large and small molecules directly to the brain across the blood-brain barrier (BBB). From this proprietary platform technology, we have created a pipeline of disease-modifying and symptomatic therapeutics for serious and progressive neurodegenerative diseases.